Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsReceivables - Net
Ratios

Lucid Diagnostics (LUCD) Receivables - Other (2021 - 2023)

Lucid Diagnostics (LUCD) has disclosed Receivables - Other for 3 consecutive years, with $10.7 million as the latest value for Q2 2023.

  • For the quarter ending Q2 2023, Receivables - Other rose 340.39% year-over-year to $10.7 million, compared with a TTM value of $10.7 million through Jun 2023, up 340.39%, and an annual FY2022 reading of $5.0 million, up 199.34% over the prior year.
  • Receivables - Other was $10.7 million for Q2 2023 at Lucid Diagnostics, up from $7.6 million in the prior quarter.
  • Across five years, Receivables - Other topped out at $10.7 million in Q2 2023 and bottomed at $1.7 million in Q4 2021.
  • Average Receivables - Other over 3 years is $5.1 million, with a median of $5.0 million recorded in 2022.
  • The sharpest move saw Receivables - Other soared 199.34% in 2022, then soared 340.39% in 2023.
  • Year by year, Receivables - Other stood at $1.7 million in 2021, then skyrocketed by 199.34% to $5.0 million in 2022, then surged by 115.67% to $10.7 million in 2023.
  • Business Quant data shows Receivables - Other for LUCD at $10.7 million in Q2 2023, $7.6 million in Q1 2023, and $5.0 million in Q4 2022.